StockNews.com began coverage on shares of Culp (NYSE:CULP – Free Report) in a research note published on Thursday morning. The brokerage issued a hold rating on the textile maker’s stock.
Culp Price Performance
NYSE:CULP opened at $5.07 on Thursday. The firm’s 50-day moving average price is $5.73 and its 200-day moving average price is $5.05. The company has a market capitalization of $63.32 million, a PE ratio of -3.57 and a beta of 1.22. Culp has a 1-year low of $4.25 and a 1-year high of $6.85.
Culp (NYSE:CULP – Get Free Report) last posted its quarterly earnings data on Wednesday, September 4th. The textile maker reported ($0.37) EPS for the quarter. Culp had a negative return on equity of 19.51% and a negative net margin of 7.88%. The business had revenue of $56.54 million for the quarter.
Insider Activity at Culp
Institutional Trading of Culp
A hedge fund recently raised its stake in Culp stock. Geode Capital Management LLC increased its holdings in Culp, Inc. (NYSE:CULP – Free Report) by 14.1% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 103,825 shares of the textile maker’s stock after buying an additional 12,830 shares during the quarter. Geode Capital Management LLC owned about 0.83% of Culp worth $680,000 at the end of the most recent reporting period. 75.05% of the stock is currently owned by institutional investors and hedge funds.
Culp Company Profile
Culp, Inc manufactures, sources, markets, and sells mattress fabrics, sewn covers, and cut and sewn kits for use in mattresses, foundations, and other bedding products in the United States, North America, the Far East, Asia, and internationally. It operates in two segments, Mattress Fabrics and Upholstery Fabrics.
Featured Articles
- Five stocks we like better than Culp
- ETF Screener: Uses and Step-by-Step Guide
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How to Invest in the Best Canadian StocksĀ
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to invest in marijuana stocks in 7 stepsĀ
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Culp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Culp and related companies with MarketBeat.com's FREE daily email newsletter.